NCT07180277View on ClinicalTrials.gov

Methylprednisolone for Moderate to Severe Traumatic Brain Injury

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

520

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

October 1, 2027

Study Completion Date

March 1, 2028

Conditions
Traumatic Brain Injury
Interventions
DRUG

Placebo

2 mg/kg diluted in 100 mL of normal saline (maximum dose 160 mg) , IV once daily for 5 days

DRUG

Methylprednisolone (MP)

2 mg/kg diluted in 100 mL of normal saline (maximum dose 160 mg) , IV once daily for 5 days

All Listed Sponsors
lead

Zhangjiagang First People's Hospital

OTHER